These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34085348)

  • 1. Editorial for "Does the Higher Relaxivity of Gadobenate Dimeglumine Permit Gadolinium Dose-Lowering in MRI of the Central Nervous System? Results of a Retrospective, Parallel Group Comparison".
    Kanal E
    J Magn Reson Imaging; 2021 Nov; 54(5):1676-1677. PubMed ID: 34085348
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
    Cheong BY; Duran C; Preventza OA; Muthupillai R
    AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
    Runge VM; Parker JR; Donovan M
    Invest Radiol; 2002 May; 37(5):269-80. PubMed ID: 11979153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.
    DeLano MC; Spampinato MV; Chang EY; Barr RG; Lichtenstein RJ; Colosimo C; Vymazal J; Wen Z; Lin DDM; Kirchin MA; Pirovano G
    J Magn Reson Imaging; 2021 Nov; 54(5):1660-1675. PubMed ID: 34018290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
    Violas X; Rasschaert M; Santus R; Factor C; Corot C; Catoen S; Idée JM; Robert P
    Invest Radiol; 2022 Feb; 57(2):130-139. PubMed ID: 34411032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage.
    Colosimo C; Ruscalleda J; Korves M; La Ferla R; Wool C; Pianezzola P; Kirchin MA
    Invest Radiol; 2001 Feb; 36(2):72-81. PubMed ID: 11224754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
    Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
    Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gadobenate dimeglumine for contrast-enhanced MRI of the breast.
    Hylton NM
    AJR Am J Roentgenol; 2003 Sep; 181(3):677-8. PubMed ID: 12933458
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
    Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.
    Rowley HA; Scialfa G; Gao PY; Maldjian JA; Hassell D; Kuhn MJ; Wippold FJ; Gallucci M; Bowen BC; Schmalfuss IM; Ruscalleda J; Bastianello S; Colosimo C
    AJNR Am J Neuroradiol; 2008 Oct; 29(9):1684-91. PubMed ID: 18599575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA.
    Vernuccio F; Bruno A; Costanzo V; Bartolotta TV; Vieni S; Midiri M; Salvaggio G; Brancatelli G
    Curr Probl Diagn Radiol; 2020; 49(6):398-403. PubMed ID: 31253462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine.
    Woodard PK; Chenevert TL; Sostman HD; Jablonski KA; Stein PD; Goodman LR; Londy FJ; Narra V; Hales CA; Hull RD; Tapson VF; Weg JG
    Int J Cardiovasc Imaging; 2012 Feb; 28(2):295-301. PubMed ID: 21337023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.
    Gilbert FJ; van den Bosch HC; Petrillo A; Siegmann K; Heverhagen JT; Panizza P; Gehl HB; Pediconi F; Diekmann F; Peng WJ; Ma L; Sardanelli F; Belli P; Corcione S; Zechmann CM; Faivre-Pierret M; Martincich L
    J Magn Reson Imaging; 2014 May; 39(5):1272-86. PubMed ID: 25006633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?
    Xing X; Zeng X; Li X; Zhao Q; Kirchin MA; Pirovano G; Wang X; Li Y; Iezzi R; De Cobelli F
    Radiol Med; 2015 Feb; 120(2):239-50. PubMed ID: 25183340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations.
    Johansson L; Kirchin MA; Ahlström H
    Acta Radiol; 2012 Dec; 53(10):1112-7. PubMed ID: 23081961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.